Insulet (PODD) Total Debt Growth (3y) (2013 - 2026)
Insulet (PODD) Total Debt Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Debt Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.92 Bn | 146.27 Bn | 6.27 Bn | 26.30% |
| 2 | Stryker | 119.50 Bn | 116.62 Bn | 3.81 Bn | 4.07% |
| 3 | Medtronic | 102.71 Bn | 94.54 Bn | 5.76 Bn | -0.07% |
| 4 | Boston Scientific | 69.72 Bn | 68.51 Bn | 3.61 Bn | 6.99% |
| 5 | Edwards Lifesciences | 49.24 Bn | 45.57 Bn | 1.29 Bn | 0.11% |
| 6 | GE HealthCare Technologies | 29.74 Bn | 27.67 Bn | 1.98 Bn | -0.34% |
| 7 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.61% |
| 8 | Dexcom | 28.96 Bn | 27.84 Bn | 750.30 Mn | - |
| 9 | Steris | 20.31 Bn | 19.88 Bn | 697.10 Mn | -14.39% |
| 10 | Insulet | 10.47 Bn | 9.99 Bn | 529.10 Mn | -12.11% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -12.11% |
| Dec 31, 2025 | -12.19% |
| Sep 30, 2025 | -10.31% |
| Jun 30, 2025 | -0.28% |
| Mar 31, 2025 | 6.18% |
| Dec 31, 2024 | 2.70% |
| Sep 30, 2024 | 2.83% |
| Jun 30, 2024 | 3.63% |
| Mar 31, 2024 | 9.51% |
| Dec 31, 2023 | 10.15% |
| Sep 30, 2023 | 15.52% |
| Jun 30, 2023 | 15.37% |
| Mar 31, 2023 | 15.82% |
| Dec 31, 2022 | 16.44% |
| Sep 30, 2022 | 12.58% |
| Jun 30, 2022 | 32.46% |
| Mar 31, 2022 | 33.17% |
| Dec 31, 2021 | 29.10% |
| Sep 30, 2021 | 30.06% |
| Jun 30, 2021 | 29.59% |